Category: North America

September 19, 2019 Off

Five Prime Therapeutics name new CEO

By BusinessWire

San Francisco based clinical-stage biotech company Five Prime Therapeutics has named the new interim Chief Executive Officer, William Ringo, who will start immediately, to replace Aron Knickerbocker, who has resigned to look for new opportunities.